Monday, October 15, 2018

NY MALE BREAST CANCER JOINT TASK FORCE: AWARENESS & SCREENING

FOR IMMEDIATE RELEASE

NYC, October 15, 2018- Dr. Robert Bard, medical director of Bard Cancer Diagnostics launches his official male-dedicated imaging and analysis program to support the growing male breast cancer cases in the northeast.

After a recent news report about 15 male breast cancer cases from 9/11 first responders in Sept, 2018, Dr. Bard and the Male Breast Cancer Coalition collaborated to form a joint task force of public awareness and a dedicated imaging program for the northeast to help address this gender-specific health threat."  When I first started doing breast imaging, we would see one or two male breast cancer cases per year- but now, I'm seeing more and more men developing benign and malignant breast tumors- mostly with firefighters," states Dr. Bard. "The rate is increasing now because of more pollutants, toxins are increasing in our environment... and elevated level of GMO, hormones and other biologically altering agents in the preservatives in our foods."


AWARENESS TO ADDRESS THE RISING NUMBERS
According to the Male Breast Cancer Coalition, government health reports show an est. of 2550 new cases in US with a mortality rate between 280-480.  This indicates that over the past 10 years, new cases are up by 22% and mortality rate is up by about 19% from previous years. Advocates collectively attribute much of these numbers due to the lack of public information, misdiagnoses and the emotional resistance in men about a commonly "female" disease.  "Our Mission is to educate people all around the world to the risk of breast cancer in men, ultimately giving men the same fighting chance that their female counterparts have... just like Lung Cancer, Brain Cancer and Liver Cancer-- it knows no gender, age or race." says MBCC co-director Cheri Ambrose. "We hope to have breast checks included in all annual physicals for men one day- combined with updated intake forms asking for cancer in families will go along way in helping to change the way breast cancer is viewed."

Since the early '70s, Bard Cancer Diagnostics has been recognized internationally for beta-testing and employing the cutting edge imaging innovations such as the 3D Doppler Ultrasonic technology to detect and battle cancer.  Dr. Bard's arsenal of high-end scanning solutions delivers real-time, accurate and non-invasive diagnostic conducts wide range of cancer diagnostic protocols including PREVENTION and EARLY DETECTION.  As a seasoned "cancer hunter", Dr. Bard is a highly-published clinical authority in some of the most common cancers cases including prostate, (female) breast, lung and skin. Adding to his list of targeted programs, his design for male breast cancer screening means a special calibration of imaging paradigm to identify and pre-determine traces of IDC invasive ductal carcinoma and other malignancies in the tissues of the male breast often found in specific areas by studying the behavior of the tumor vascular flow under the skin.  The program also addresses continued monitoring for RECURRENCE PREVENTION (which has been reported in a significant percentage of male breast cancer cases)."


NY COMMUNITY OUTREACH TO BATTLE MALE BREAST CANCER
Aside from a longstanding career in advanced cancer imaging,  Dr. Bard spends additional time conducting educational seminars for the medical community and awareness projects on the public front. He allied with Awareness for a Cure, a non-profit group supporting the membership and fundraising of all local cancer orgs.  He was recently elected as one of the top members of the Medical & Scientific Advisory Board for the Male Breast Cancer Coalition for his contribution to building a male cancer scanning and recurrence prevention program.



Monday, October 8, 2018

MALE BREAST CANCER CHECKUPS- THE NEXT NORMAL!



It is all too common in human nature to fear what we do not know and conceal what may alienate us. From the success of awareness groups such as the Male Breast Cancer Coalition, the growing trend of male breast cancer cases is coming to light throughout the media and slowly evolving out of being a "rare" cancer as men are now finding their way to get checkups.  My office is starting to see more and more male breast cancer cases lately thanks to environmental pollutants, toxins, unhealthy foods and the many cancer-causing influencers in our daily lives.

Ret. Chief Larry Overcast- Firefighter turned Breast Cancer Missionary
I was first alerted to this by the firefighters at 9/11 who were developing breast tumors at an unheard of high rate. When I first started doing breast imaging, we would see one male breast cancer a year. Now, many of the firefighters are developing benign and malignant breast tumors (see image).

Men are unwilling to have mammograms for two reasons: it hurts, and it misses a lot of small cancers.  Our 4-D Advanced Sonogram has become the very first diagnostic test specific for male breast cancer not only because of its effectiveness but the entire scanning experience is so different that it practically gives the patient full control of what they're seeing and what I'm looking for.

Immediately, you can see if it's suspicious or not. Together, we can identify benign breast tumors that don't need to be biopsied. Should there be anything suspicious, seeing the cancer with the sonogram lets you work the next step which includes working a tiny needle underneath the skin under ultrasound guidance. You can see the needle go directly into the tumor, aspirate a few times, and send the biopsy sample out for diagnosis.  That kind of real-time activity and control brings so much relief to my patients. It's also a much more effective system to find and diagnose it all in the same short setting.

CURING THE STIGMA
Men continue to be afraid to visit women's imaging centers or a facility with a waiting room full of women. They're even afraid to touch their own breasts for a self-checkup. I was taking care of one of the 9/11 firefighters for early cancer detection of the lung, the thyroid, the prostate and the liver. As I finished the exam, and was walking out, he said, "Doc, I think I have a lump under my arm." I scanned under his arm, and of course, there was nothing, so he said, "Let me find it." And he couldn't find it. Then I said, "Look, I can see under the skin easily", and as I was moving the probe towards the breast, he was looking at the screen because I was looking at the probe, and he saw this big white area and yelled, "Doc, what is that?" And I said, "This white area, if this was black, this is a metastatic lymph node. But since it's white, it's benign fatty tumor."

Where male breast cancers are concerned, my imaging center has always been compassionate about privacy as far as addressing the emotional impact in cancer patients.  I understand their concerns after working on prostate cancer imaging for 30 years and written two textbooks on prostate cancer.

The ultrasound is quick (5 minutes or less), real-time and painless and a most accurate way to diagnose ANY cancer, making it that much more comfortable for men in the office. And if they are worried about something else, like a bump on the skin, or a mole on their back, or some funny feeling or change in their breasts or under their arm, we can check that at the same visit. It's simply putting on a different probe that goes over the skin, looking and taking a picture.

For more information, visit: www.MBCSCAN.com

...................................................................................................................................................................

Sponsored in part by:



Efficient Scanning of BIA-ALCL (Implant related cancer)- part 1

An interview with Dr. Robert Bard, digital breast imaging specialist



My understanding of Breast implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is that it's a cancer caused by long standing breast implants.  It seems to be more common in the textured breast implants as opposed to the smooth breast implants but it does happens in both. So this has recently been highlighted because the more we're doing screening with ultrasound and with MRI we're finding more of these cases that are early and thus asymptomatic. 

The seroma or fluid collection around the implant is best identified by ultrasound.   All the imaging like CT, MRI, and Ultrasound can detect fluid, it just depends how fine a resolution or how small a fluid that you want. The beauty of the Ultrasound is, not only does it detect the fluid, but since the implant is near the skin, we can see if the fluid and associated tumor are breaking through the skin surface.  Sometimes the fluid causes inflammation of the skin, because it's on top of the implant, and we can measure the thickness of the skin, which MRI and CT cannot do.

TEXTURES
A textured implant acts like a foreign body. Imagine getting a splinter under the skin; first it hurts, then the pain goes away but it starts to swell and become infected with pus and may even burst out through the skin. The same way the textured implant causes the inflammation. And we know chronic inflammation is associated with cancer. This is a reason to have textured implants scanned periodically with the simple safe sonogram to make sure there's nothing developing. The textured implant is 90% more likely to cause a reaction and the ALCL cancer than the smooth implant.


All late onset fluid collections should be aspirated and tested regardless of how small because you don't want to miss a potentially curable early cancer, if you don't catch it early, and it spreads, then the treatment is much more radical.

Imaging through ultrasound technology can accurately access fluid amount, even if the fluid is behind the implant. In fact, fluid detection from anywhere in the body, is most easily detected by ultrasound.  We have different probes so if the fluid is deep, we use a probe that focuses more deeply like behind the implant. But, It takes a few seconds with a regular probe to find the fluid especially since the patient is vertical (sitting up) during the exam which makes the fluid completely dependent.

TYPES OF FLUIDS AROUND THE IMPLANT
There's two types of fluids; there's very clear fluid which registers in the monitor as looking completely black.  But cancerous fluid appears if you have a negative fluid aspiration report. You have to go back to the breast and scan and look for either solid tumors or fluid in other areas. Because the cancer fluid tends to be "laculated", cloudy, sticky or compartmentalized.  Hence, sonography can really find more-- it can be more accurate if you look harder and have the right equipment.   

The investigation of this unusual disease is so early that in the case of preventing false negatives, there are new optical technologies that I work with, that come from Israel, and the Boston Medical Centers, that may be able to do this in the very near future.  For women with negative fluid tests, you can have an MRI, which covers a broader area, however, make sure that the person who did the Ultrasound is skilled and has looked all over the breast, both on top and behind, and also looked for the solid cancers that can be anywhere surrounding the implant.

A year ago an allergist sent me a patient with a red breast. The skin was discolored and red and painful. He thought it was an allergy. Since she had a breast implant, we scanned it and we found out, not only was the skin thickened but also, there was fluid surrounding the breast implant. Once you see fluid around a textured breast implant, you are automatically alluded to the possibility of the ALCL disorder. And if you do see fluid, we next scan the entire breast for solid tumors that may be in the area of the fluid or distant around the implant from the fluid. And then we check for metastatic disease to the lymph nodes. So we look at the breast and then we see the lymph nodes that actually are between the ribs by the breast bone. And we also look at the more common spread areas of the lymph nodes under the arm.  

THE DIFFERENCE BETWEEN BENIGN SCAR TISSUE AND BIA-ALCL
Scar tissue is generally benign but the tumor can be adjacent to the scar tissue. Fortunately when we use our very high resolution machines, we can differentiate between scar tissue and tumor. More importantly we can use the doppler flow capacity which shows vessels in the tumor because scar tissue does not have any blood vessel flow, it's dead essentially. And tumors need blood vessels to grow. So with a push a button we can put on the power doppler and many other blood imaging technologies we have and see that there are tumor vessels that are next to the scar in the tumor. So yes we can differentiate the two. 

A smart protocol is to test all masses and areas of increased density near a breast implant to rule out BIA ALCL. A simple ultrasound scan is the quickest and most cost effective (and frankly most accurate) way to find this.  Make sure your technician is trained in breast imaging and in ultrasound to specifically do imaging of the breast. There's special certifications for mammography and breast ultrasound and you need the 3D and 4D high resolution equipment to show small fluid collections in and behind the skin. 

ASPIRATION VS BIOPSY
Sometimes, a woman is told that a mass should not and cannot be biopsied because it could rupture the implant.  For this, we conduct an FNA (Fine Needle Aspiration) using needles to extract fluid or cells similar to taking a blood sample.  These needles are so fine you can barely fell them break the skin to do these fine needle aspirations.  It's a relatively small needle to take out the fluid. Or if it's a larger needle for a bigger biopsy, since we do it under image guidance, you can avoid the breast implant. 

For more information, visit: www.cancerscan.com
...................................................................................................................................................................


ABOUT THE AUTHOR:
Robert L. Bard, MD, PC, DABR, FASLMS is internationally known and recognized as a leader in the field of 21st Century 3-D ULTRASONOGRAPHIC VOLUMETRIC DOPPLER IMAGING. Dr. Bard specializes in advanced 3-D sonography to detect cancers in numerous organs including the breast, prostate, skin, thyroid, melanoma and other areas. Dr. Bard’s images are used to accurately guide biopsies, target therapy and provide focused follow-up after treatment.  Dr. Bard is currently in consulting practice in New York. He appears frequently on regional television, national radio and is a consultant to major healthcare organizations. He is committed to improving non-invasive cancer testing and developing minimally invasive image guided technologies to prevent cancer spread through his foundation, The Biofoundation for Angiogenesis Research and Development. In his role as director of BARD CANCER DIAGNOSTICS, he lectures at Mt. Sinai Medical Center, NYU Medical Center and leading international hospitals in England, France, Spain and the Netherlands.


ADDITIONAL ARTICLES & REFERENCES:
Cancer Alert: Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

SPECIAL THANKS TO:
BardCancerDiagnostics: Early Detection Program
Male Breast Cancer Scan (www.mbcscan.com)
Jennifer Hunt & LI2DAY
Jennifer Cook Roth of the BIA-ALCL group (fb)
Modern Pain Relief - Professional Network



LEGAL DISCLAIMER

Thursday, August 30, 2018

The Doppler Ultrasound for Cancer Scanning; Not Your Obstetrician's Sonogram

When you think "sonogram", what might come to the average mind is probably a blurry scan of an expectant mommy's tummy from an obstetrician's clinic.  But the advancements in ultrasound technology has been widely expanded upon by European medical engineers and clinicians and is used more commonly to challenge the performance of all other imaging equipment to accurately capture complete diagnostics of some of the most complex examinations - such as CANCER.

Below is an excerpt from Dr. Robert Bard's interview at WIOX Radio (Soul Traveler Healing Journeys show with host, Kevin Misevis)

EUROPEAN SMART IMAGING RESHAPES U.S. MEDICINE
Sonography has been used for over 50 years for diagnosing everything from cancer tumors and cysts to microfractures on bone.  As the technology has gotten better and medical practice has taken advantage of the new computers, we can do so much more and do it better.   Most of the advances in ultrasound have occurred in Europe. The United States is slightly slow in recognizing some of the medical advances, particularly in the field of ultrasound imaging. A lot of the training I did was in Europe (Spain and France) so I brought back European technology and European ideas to New York.

With that said, my advanced American-made equipment shows not only the picture itself, but we can see the picture in motion in real-time. For example, we can see blood flow in a tumor. Now, the blood flow in a tumor is like seeing a hurricane or a storm on a weather map. We see the blood flow in an area that you're studying, (such as the prostate, for example) and it's got one or two cancer vessels, it's bad. If it has 10 cancer vessels, it's very bad.

This is the technology we have today that's widely available. We have regular ultrasound, safe sound waves, and we have the blood flow technology.  However, further development allows us to do three dimensional ultrasound imaging. Once you have 3D, you get the entire volume of an area.  What's even more interesting is with the special technology, if the exam is performed by a physician, as it generally is not in the United States, in Europe and Asia, the doctors who interpret the exam also do the sonogram, so once you've got an image on it, you can take a 3D picture and then using another modality on the machine, you get into 4D imaging, so anything you're seeing in three dimensions, you can expand or adjust so you can see the borders much more clearly.  That means if somebody's got a prostate cancer, for example, we can tell them not only how big it is, but also how aggressive it is. More importantly, with the 3D or 4D imaging, we can look at the capsule, the margins of a tumor to see if the margins are irregular or if the tumor has broken outside, say, of the prostate capsule that holds the gland intact. With all this new technology, we can do many things that didn't used to be possible and more than what other imaging devices fall short of.

Accuracy depends on the area being scanned. Specifically in skin cancer, we're 99% accurate. This means that a high resolution sonogram of the skin for melanoma specifically is more accurate than the biopsies, which can be random in nature on the skin, and this was first reported by the French Cancer Institute 20 years ago, so this is not a new technology. 20 years ago, it was 99% accurate at detecting the penetration of a malignant melanoma tumor.  For other areas such as the prostate, with the right technology, we have a 99% accuracy rate of telling a patient if there's no active cancer present, so we can determine with a high degree of certainty that whatever they're worried about, whatever the blood tests show or whatever the finger feels, it won't kill you.

Identifying the accuracy of a real cancer, we have I'd say a 95% accuracy with the specialized equipment. But the major test for the prostate is the PSA blood test.  In 2004, in the Journal of Urology, they said that the accuracy of the PSA test for detecting cancer is 2%,  It's not very accurate. Specifically, what I tell my patients is the finger is two times more accurate. The digital rectal exam of the prostate is two times more accurate for finding high grade prostate cancer than the PSA, and it goes up to 3% accuracy if I do it myself.


EVOLUTION & ADVANCEMENT OF DIGITAL IMAGING
In 1974, when I was in training as a resident in radiology, my chief of service said, "What area of radiology do you want to specialize in?" I said, "Diagnostic ultrasound," and he laughed at me.   Since then, ultrasound has become the primary diagnostic tool used throughout the world. In other words, it's the first study for almost everything, but then again, you've got to have the equipment and the training and the interest, and America has not kept pace with the world's usage of advanced modern technology.

This is highly accurate. Indeed, patients are finding problems and we can tell them if the problem is really serious or not, much  like a "digital biopsy". Basically, the accuracy is so high now that doctors are starting not to biopsy.  For example, we used to biopsy a cyst in the kidney 40 years ago, and now we see it on sonogram and we say if it's a cyst, you watch it. You don't biopsy anymore. The same thing, about 20 years ago, we stopped biopsying cysts in the breast because you can see it's a simple fluid-filled sac.

READING BLOOD FLOW TO STUDY TUMORS
Now, with the advances in blood flow technology, which are confirmed by the CT and MRI technology, which I use concomitantly, in other words, if you see something on a 3-D Doppler Sonogram in the prostate, you do get a confirmatory MRI. Oftentimes, people decide to get treated and be followed because we can non-invasively watch the treatment progress.  In other words, remember I said 10 cancer blood vessels in a tumor? If you start a treatment and it goes down to five in a month, you're winning, and if it goes down to one after six months, you're definitely winning. It's a way to follow up a cancer treatment as well as to tell people how aggressive it is.

Wednesday, August 15, 2018

Cancer Alert: Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Note: The original publishing of this article is from AWARENESS FOR A CURE and PinkSmart News on July 31, 2018. (LINK)  This article is an overview reflecting a recent health alert from various medical centers and clinicians about a possible cancer risk resulting from a specific type of breast implant.  If you may recognize yourself to be a candidate or have received a similar notice from your reconstructive surgeon, please contact your physician to get more details.

Since 2011, the FDA identified a confirmed link to a specific type of breast implant and breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL - a form of cancer of the immune system called non-Hodgkin’s lymphoma.  The World Health Organization (WHO) describes BIA-ALCL as a T-cell lymphoma that may arise within 7-8 years after the insertion of breast implants with textured surfaces.  Half of the reported cases were diagnosed with persistent SEROMA, a buildup of fluid around the implant region (see image) and presenting symptoms of swelling, pain, and redness and breast asymmetry of the affected breast.

By 2017, 359 cases of ALCL has been reported thus far and 9 deaths (2.5%) have been identified since the inception of this study where the majority of cases reported had textured implants versus smooth implants.  The very texture of the implant's coating has been said to cause inflammation and scarring that can led to lymphoma, while others attribute the texture to trap bacteria which leads to cancer.

According to the FDA, certain manufacturers have been reviewed and connected with implant-specific risks since 1999 associating their textured implants with ALCL.  Worldwide, approximately 1.4 million breast augmentations were performed in 2015. In the United States, 290,467 breast augmentations were performed in 2016; this represented a 37% increase from 2000.  BIA-ALCL most commonly occurs in patients of a median age of 52 years. The median time interval between breast implant and diagnosis is 9 years and ranges from 1 to 32 years.

Jennifer Cook, a diagnosed victim-turned advocate of BIA-ALCL awareness is promoting a global mission and educational program to support all women who are potential sufferers of this problem. "...there is extreme urgency because this disease can go from being curable with surgery to a disease that may take your life quickly-- because it's advanced...(in) a matter of a few months." In a private interview, she detailed her personal research and her actual experience of self-checking and finding anomalies and unusual feelings that breast surgeons addressed only with minimal concern. Her pro-activeness and perseverance led her to a powerful direction of self-preservation. "it was the biopsy of that lump that led to my diagnosis. I actually had a mass that was diagnosed before the explant ... like most cancers, you know the sooner you get to it, the much better chances you have.  The situation is obviously a huge concern because currently experts are advising women who test negative, that their seromas are benign and that they do not necessarily need to have their implants removed. We feel that this is misleading given the fact that at least five women we know of have recently had negative fluid but positive capsules."

Because BIA-ALCL has generally only been identified in patients with late onset of symptoms, implant removal in patients without signs or symptoms is not recommended.  Dr. Robert Bard, a NYC based cancer imaging diagnostician recommends a regular monitoring schedule for any adjustments or shifts in the current stasis of the implant and its surrounding area. "Fluid build up may be easily imaged by 3D sonography although it can be detected by MRI scans as well (9). Under ultrasound guidance, fluid may be aspirated and analysed in real time without rupturing the implant or puncturing nearby arteries."

It has been noted that among operable patients, total capsulectomy with removal of suspicious lymph nodes is the first line of treatment and complete surgical excision (capsulectomy and implant removal) resulted in better overall survival and event-free survival compared to patients who underwent a limited surgery or treatment with systemic chemotherapy or radiation therapy.

..............................................................................................................................................................

REFERENCES:

9) Bard R, 8th International Workshop on PET in lymphoma, Menton, France 2018

10) ALCL In Women With Breast Implants BIA-ALCL:

..................................................................................................................................................................................................
DISCLAIMER:

The information provided in this article is a compiled report from public websites whose links are listed in the REFERENCE section and the statements and quotes included are from actual interviews by those whose names are stated who provided express consent to the publishing of this material.  This article is not meant to be used to diagnose, treat or advise others about what actions they should take with regard to any medical condition.  No one should undertake or discontinue any treatment as a result of what they read on our blogs. The publisher(s), editors, sponsors or other  "supporting members" of AwarenessforaCure.org are providing a strictly educational service and are not responsible for the diagnosis or treatment of any specific health needs. and are not liable for any damages or negative consequences from any treatment, action, application or preparation to any person(s) reading the information in this article or its thread. Readers with medical needs should obtain appropriate professional medical supervision. References are provided for any informational purposes only and do not constitute endorsement of any websites or other sources.

Sunday, July 8, 2018

LONG ISLAND BREAST CANCER & THE ROAD TO DOPPLER IMAGING

By: Dr. Robert Bard





In 1976, during my early days as a young radiologist, I was approached by Dr. Henry Leis Jr., the pioneer doctor who wrote the very first text on breast cancer and developed mammography 18- a means of early diagnosis and instrumental in the use of many of the less invasive procedures used in the treatment of breast cancer today.

He confessed with great concern that he had all these patients with lumpy or cystic breasts developing tumors that he could clearly feel but the mammogram kept missing it.  Seeking my help through sonogram technology, we worked on his patients together and the sonogram clearly identified and quickly diagnosed a mass as either a cancer or a benign cyst, in a dense, lumpy breast.  Since then we've incorporated the sonogram in high-risk patients’ regimen every six months religiously because it finds tumors while they're small and “lumpectomy” surgery is curative if the mass is less than 1 cm.  This is alongside doing mammograms once a year in women over 50 or unless they have a history of cancer- at which case, we do it starting at age 45.


LONG ISLAND CANCER- THEN AND NOW
Since the early 1940’s, Long Island became riddled with countless cases of toxic waste and hazardous dump sites contaminating groundwater and wells with volatile organic chemicals and carcinogens.  Much of this was known as the Bethpage Plume thanks in part to the Grumman manufacturing plant, Naval Weapons Industrial Reserve plant and Hooker Chemical/Ruco Polymer site.  Record levels of radioactive materials such as chromium and radium continue to plague its drinking water today despite decades of cleanup efforts and water treatment plant upgrades.  Scientists have speculated a direct connection between Long Island’s reportedly high rate of breast cancer (alongside other cancers) over the national average and this cancer plume.

In 1985, a major study of Long Island patients in the NY State Journal of Medicine showed over 90% of the suspect calcifications that showed up in mammograms were proven benign after surgical biopsy, resulting in unnecessary treatments that nowadays are avoidable.  Unfortunately, the increase in inflammation in the breast which was causing the calcification was what instigated the greater risk of developing actual breast cancer. The current 2018 American College of Radiology statistics state that women with dense breasts are 500% more likely to develop benign, or malignant tumors than women without dense or lumpy breasts.

To address this overdiagnosis, they started using the MRI to detect breast cancer in the 1990’s- but this too showed inconsistent levels of inaccurate readings as far as things that looked suspicious and looked like breast cancer- similar to Dr. Leis’ negative mammogram readings.   By the advancement of the new 3D ultrasound systems, we were able to find and discern a true cancer from a cyst, or one of these benign post-inflammatory reactions mimicking a cancer on the MRI and the mammogram.

Some women (with diabetes as one example) tend to have inflammation that forms lumpy areas in the breast which causes scarring - scarring that can give a false reading and actually feels like a breast cancer.  Scenarios like these tend to trick the less experienced diagnostician or older technologies into false reports.   Since the introduction of the Doppler blood flow technology, we are able to see the entire cancer vessels and actually gives you a road map to the tumor. The 3D technology allows you to look at the map and measure how many cancer vessels there are. In patients who are taking non-traditional treatment or on immune or chemotherapies, you can see if the number of cancerous vessels are larger, which means the treatment is failing. Or, if it goes from five blood vessels down to one tumor vessel- an indication that the treatment is working.

WHY GO DOPPLER?
There are other ways of looking at blood flow in tumors. CAT scans and CT radiation imaging was spectacular at finding breast cancer except the radiation dose was so high that patients were developing lung cancer from it. Also, claustrophobic people couldn't fit into the CT or the MRI tube. MRI also uses the blood flow technology but some people are allergic to the contrast from the CT or the MRI. We also learned that the MRI contrast is depositing now in the brain, causing other problems that we're just being aware of. 

The Doppler Sonogram is technically instantaneous. You put the probe on the breast, find the area, pinpoint it, press a button and seconds later you have the map showing the types of vessels, the location of the  vessels. You have a program on the computer to give you a vessel density measurement which shows how aggressive this is. Instead of the genetic markers, which are very popular, showing how aggressive a tumor will be, this is a visual way in seconds that's being used worldwide to show cancer vessel aggression. Tumor aggression by blood flow evaluation is used worldwide in nuclear medicine, CT  scans and MRI technology, however, the simplest way is the non invasive 3D Doppler breast procedure.


Additional References:
1) Local clustering in breast, lung and colorectal cancer in Long Island, New York

2) Breast Cancer Incidence- Nassau County, 2005-2009

3) 3-D Doppler Ultrasound Helps Identify Breast Cancer

4) Doppler ultrasound scoring to predict chemotherapeutic response in advanced breast cancer
...................................................................................................................................................................

For more information or to discuss the many benefits of ADVANCED ULTRASONIC DOPPLER IMAGING, contact us directly at:  212.355.7017 or email: appt@barddiagnostics.com

Monday, April 30, 2018

Advanced Diagnostics and the Rise of Post 9/11 Aggressive Cancers


by: Dr. Robert Bard

I started my career in medicine in 1968 and enlisted in the US Air Force during the Vietnam era as a radiologist. There I learned the discipline of immediate response to the call of duty, whether it be for the protection of our country or rescuing human life. The 9/11 tragedy brought out that same spirit when our first responders called for help.

I extended my practice to the many police personnel, firefighters, contractors and volunteers who were exposed to toxins or were injured in ground zero during and after that fateful attack, and one by one, cases of knee and hand injuries from rescuers who struggled with the many flights of stairs of the towers or dug out hot and heavy rubble to respond to cries for help. I also handled other TRAUMA cases like eye injuries where my technology was the most effective way to quickly and accurately identify a dislocated lens, retinal detachment and foreign matter (glass or splinter) that made its way behind the swollen eye lid or into the blood stream.  My group tackled each injury with the best of care, compassion and the highest commitment to recovery using minimally invasive sonogram diagnostics.

A decade or so later, news broke of unique and advanced cases of CANCER arising in droves.  The same individuals exposed to the toxic fumes and plumes of hazardous particles of the danger zone contracted aggressive cases of CANCER and were in immediate demand for medical care and support.  My practice was no stranger to this dilemma as I began meeting and diagnosing cancer tumors in the lung, liver, kidney, brain, skin and eye probably related to 9/11 exposure.

I personally met James Zadroga in 1992 at a public event. The name did not impact me until way past his untimely demise on 2006. Having connected with John Feal of the FealGood Foundation, we put all the pieces together as far as the extensive yet never-ending work that still has yet to be done to bring much needed support, compensation and political awareness to help the many survivors and affected rescuers of the 9/11 disaster.  The Zadroga Compensation Act was established (2011) by a group of D.C. advocates who drove legislation to ensure that those exposed to the 9/11 disaster continue to receive monitoring and treatment services for 9/11-related health problems through at least until 2090.

My practice, BARD CANCER DIAGNOSTIC IMAGING (NYC) has isolated and scanned countless cases of cancers using the most advanced diagnostic imaging technologies worldwide.  We provide early detection and real-time "digital biopsies" of many tumor types using 4D Doppler innovations bringing accuracy and expedience to the most comprehensive report- within MINUTES.  For our patients, this is a priceless advantage that cuts down the wait time, decreases travel (to multiple diagnostic centers) and reduces the insurmountable level of stress and intolerable problems of today’s increasing medical bureaucracy.  Our technology outperforms the advantages of MRI, X-ray and CT scans by 20-to-1.  We have an uncompromising system that’s unique to the industry whereby our combined experience and technical advancements are called upon by many university hospitals and private practices today.  My services were recently utilized during the terror attack in Nice by the truck driver who mowed down innocent civilians on the French Riviera where-x-ray and CT services were overwhelmed (I am a current member of the French Radiology Society-Societe Francaise de Radiologie and have been since 1999)

If you may have been recently diagnosed or have realistic concerns about 9/11-related cancers, contact us immediately at 212.355.7017.  We are available to discuss your options and work with your physician on the many ways that our advanced 4D Digital Diagnostic System for post 9/11 trauma or cancer cases can help you.  We are ready to work with the current compensation benefits fund to get you the best noninvasive diagnostic treatment available.

............................................................................................................................................................

John Feal and the FealGood Foundation: ENSURING CANCER CARE FOR 9/11 FIRST RESPONDERS

Nesconset, NY (April 20, 2018) - Meet Long Island's own John Feal- an injured Ground Zero contractor turned national super-advocate and champion for the prevalence of the 9/11 VICTIMS COMPENSATION FUNDTHE WORLD TRADE CENTER HEALTH PROGRAM and the JAMES ZADROGA ACT. He founded the FEALGOOD FOUNDATION, the largest 9/11 support organization in the country-borne from frustration to the inaction and lack of governmental support. He built a life-long career out of helping the many health victims from the 2001 disaster receive the financial compensation they deserve and gain a complete understanding of their rights for all 9/11 related injuries. His non-profit org is recorded as one of the largest fundraisers for this mission- amassing over $8.5M of active funding for the compensation bill plus another $5M raised to add to the WTC fund for first responders (since the inception of FGF in 2005) from online donations and public fundraising. John Feal became a major voice for all first responders working tirelessly between local and national fronts to gain legislative stakes for the rights of all those exposed to the many health hazards of ground zero.

By 2010, a new form of devastation appeared out of the shadows: a significant number of advanced and aggressive cancer cases suddenly grew within the many surviving rescuers and ground zero exposed. These victims were formerly cleared of any illnesses at first testing are now showing surprising numbers of cases of over 68 cancer types in the blood, brain, lung, liver, thyroid and skin. The 2010 bill was passed at a time when there were NO cancer cases, hence funds and congressional support was not prepared for any of this. The tsunami wave of new cancers that mutated after 8-10 years of dormancy does not even (yet) account for the "asbestos cancer... because that takes 20 years on average to manifest in the body, and we're now going on year 17," says Feal. Hence, new lobbying efforts for advanced cancer care treatment are now in full swing and Mr. Feal faces an even larger hurdle to upgade his mission to meet the current needs. (Complete interview coming soon.)

To learn more about the FealGood Foundation or to Donate, visit: www.fealgoodfoundation.com

...................................................................................................................................
Science Feature as seen on Rejuvenate! E-magazine

Tuesday, April 24, 2018

John Feal and the FealGood Foundation: ENSURING CANCER CARE FOR 9/11 FIRST RESPONDERS

Nesconset, NY (April 20, 2018) - Meet Long Island's own John Feal- an injured Ground Zero contractor turned national super-advocate and champion for the prevalence of the 9/11 VICTIMS COMPENSATION FUND, THE WORLD TRADE CENTER HEALTH PROGRAM and the JAMES ZADROGA ACT. He founded the FEALGOOD FOUNDATION, the largest 9/11 support organization in the country-borne from frustration to the inaction and lack of governmental support. He built a life-long career out of helping the many health victims from the 2001 disaster receive the financial compensation they deserve and gain a complete understanding of their rights for all 9/11 related injuries. His non-profit org is recorded as one of the largest fundraisers for this mission- amassing over $8.5M of active funding for the compensation bill plus another $5M raised to add to the WTC fund for first responders (since the inception of FGF in 2005) from online donations and public fundraising. John Feal became a major voice for all first responders working tirelessly between local and national fronts to gain legislative stakes for the rights of all those exposed to the many health hazards of ground zero.

By 2010, a new form of devastation appeared out of the shadows: a significant number of advanced and aggressive cancer cases suddenly grew within the many surviving rescuers and ground zero exposed. These victims were formerly cleared of any illnesses at first testing are now showing surprising numbers of cases of over 68 cancer types in the blood, brain, lung, liver, thyroid and skin. The 2010 bill was passed at a time when there were NO cancer cases, hence funds and congressional support was not prepared for any of this. The tsunami wave of new cancers that mutated after 8-10 years of dormancy does not even (yet) account for the "asbestos cancer... because that takes 20 years on average to manifest in the body, and we're now going on year 17," says Feal. Hence, new lobbying efforts for advanced cancer care treatment are now in full swing and Mr. Feal faces an even larger hurdle to upgade his mission to meet the current needs. (Complete interview coming soon.)

To learn more about the FealGood Foundation or to Donate, visit: www.fealgoodfoundation.com

...................................................................................................................................
Science Feature as seen on Rejuvenate! E-magazine



............................................................................................................................................................

NY MALE BREAST CANCER JOINT TASK FORCE: AWARENESS & SCREENING

FOR IMMEDIATE RELEASE NYC, October 15, 2018- Dr. Robert Bard, medical director of Bard Cancer Diagnostics launches his official male-dedi...